Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity

Immunity - Tập 43 - Trang 240-250 - 2015
Gail D. Sckisel1, Myriam N. Bouchlaka1, Arta M. Monjazeb2, Marka Crittenden3,4, Brendan D. Curti3,4, Danice E.C. Wilkins5, Kory A. Alderson5, Can M. Sungur1, Erik Ames1, Annie Mirsoian1, Abhinav Reddy1, Warren Alexander6, Athena Soulika1,7, Bruce R. Blazar8, Dan L. Longo9, Robert H. Wiltrout10, William J. Murphy1,11
1Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA
2Department of Radiation-Oncology, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA
3Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213, USA
4The Oregon Clinic, Portland, OR 97220, USA
5Department of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA
6The Walter and Eliza Hall Institute of Medical Research, Parkville, Vic. 3050, Australia
7Institute for Pediatric Regenerative Medicine, Shriner’s Hospitals for Children – Northern California, Sacramento, CA 95817, USA
8Department of Pediatrics, Division of Blood and Marrow Transplantation and the University of Minnesota Cancer Center, Minneapolis, MN 55455, USA
9Laboratory of Genetics, National Institute on Aging, Baltimore, MD 21224, USA
10Cancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, USA
11Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA

Tài liệu tham khảo

Appay, 2002, Premature ageing of the immune system: the cause of AIDS?, Trends Immunol., 23, 580, 10.1016/S1471-4906(02)02338-4 Attia, 2005, Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4, J. Clin. Oncol., 23, 6043, 10.1200/JCO.2005.06.205 Berner, 2007, IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy, Nat. Med., 13, 354, 10.1038/nm1554 Boyman, 2006, Selective stimulation of T cell subsets with antibody-cytokine immune complexes, Science, 311, 1924, 10.1126/science.1122927 Chu, 2013, Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner, Cell Rep., 3, 701, 10.1016/j.celrep.2013.02.020 Comin-Anduix, 2008, Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma, J. Transl. Med., 6, 22, 10.1186/1479-5876-6-22 Geginat, 2001, Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells, J. Exp. Med., 194, 1711, 10.1084/jem.194.12.1711 Jenkins, 1987, Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo, J. Exp. Med., 165, 302, 10.1084/jem.165.2.302 Johnson, 1999, Prevalent class I-restricted T-cell response to the Theiler’s virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28, J. Virol., 73, 3702, 10.1128/JVI.73.5.3702-3708.1999 Jonjić, 1989, Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes, J. Exp. Med., 169, 1199, 10.1084/jem.169.4.1199 Khaitan, 2011, Revisiting immune exhaustion during HIV infection, Curr. HIV/AIDS Rep., 8, 4, 10.1007/s11904-010-0066-0 Kimura, 2013, IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death, Nat. Immunol., 14, 143, 10.1038/ni.2494 Madiehe, 2001, Constitutive activation of STAT-3 and downregulation of SOCS-3 expression induced by adrenalectomy, Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R2048, 10.1152/ajpregu.2001.281.6.R2048 Maker, 2005, Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study, Ann. Surg. Oncol., 12, 1005, 10.1245/ASO.2005.03.536 Matloubian, 1994, CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection, J. Virol., 68, 8056, 10.1128/JVI.68.12.8056-8063.1994 Monjazeb, 2014, Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help, PLoS ONE, 9, e102709, 10.1371/journal.pone.0102709 Moriggl, 1999, Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells, Immunity, 10, 249, 10.1016/S1074-7613(00)80025-4 Murphy, 2003, Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses, J. Immunol., 170, 2727, 10.4049/jimmunol.170.5.2727 Palmer, 2009, Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function, Trends Immunol., 30, 592, 10.1016/j.it.2009.09.009 Perona-Wright, 2010, Sustained signaling by canonical helper T cell cytokines throughout the reactive lymph node, Nat. Immunol., 11, 520, 10.1038/ni.1866 Sachdeva, 2010, Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients, J. Acquir. Immune Defic. Syndr., 54, 447, 10.1097/QAI.0b013e3181e0c7d0 Sauce, 2013, Monitoring cellular immune markers in HIV infection: from activation to exhaustion, Curr. Opin. HIV AIDS, 8, 125, 10.1097/COH.0b013e32835d08a9 Schoenberger, 1998, T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions, Nature, 393, 480, 10.1038/31002 Schwartz, 2003, T cell anergy, Annu. Rev. Immunol., 21, 305, 10.1146/annurev.immunol.21.120601.141110 Sckisel, 2014, Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function, Clin. Exp. Immunol., 175, 79, 10.1111/cei.12186 Seung, 2012, Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses, Sci. Transl. Med., 4, 137ra74, 10.1126/scitranslmed.3003649 Stevenson, 1998, Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice, Proc. Natl. Acad. Sci. USA, 95, 15565, 10.1073/pnas.95.26.15565 Sun, 2003, Defective CD8 T cell memory following acute infection without CD4 T cell help, Science, 300, 339, 10.1126/science.1083317 Teijaro, 2013, Persistent LCMV infection is controlled by blockade of type I interferon signaling, Science, 340, 207, 10.1126/science.1235214 Tietze, 2011, Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?, Int. Rev. Immunol., 30, 238, 10.3109/08830185.2011.598977 Tietze, 2012, Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy, Blood, 119, 3073, 10.1182/blood-2011-07-369736 Tough, 1999, Stimulation of naïve and memory T cells by cytokines, Immunol. Rev., 170, 39, 10.1111/j.1600-065X.1999.tb01327.x Verdeil, 2006, STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors, J. Immunol., 176, 4834, 10.4049/jimmunol.176.8.4834 Willerford, 1995, Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment, Immunity, 3, 521, 10.1016/1074-7613(95)90180-9 Wilson, 2013, Blockade of chronic type I interferon signaling to control persistent LCMV infection, Science, 340, 202, 10.1126/science.1235208 Yoshimura, 2007, SOCS proteins, cytokine signalling and immune regulation, Nat. Rev. Immunol., 7, 454, 10.1038/nri2093 Zhao, 2010, Interleukin-2 inhibits polarization to T helper type 1 cells and prevents mouse acute graft-versus-host disease through up-regulating suppressors of cytokine signalling-3 expression of naive CD4+ T cells, Clin. Exp. Immunol., 160, 479, 10.1111/j.1365-2249.2010.04089.x